Introduction: Multiple myeloma (MM) is a plasma cell malignancy originating from bone marrow. Genetics has proven to impact MM susceptibility, with genome-wide association studies (GWAS) discovering 23 genetic loci associated with MM risk. However, MM remains an incurable disease, with much of its heritability unexplained. We hypothesize that SNPs with predicted functional roles have an increased chance of association with MM susceptibility. Specifically, the stringent significance threshold (p<〖5 x 10〗^(-8)) used in GWASs, accounts for the numerous statistical tests performed, increasing the risk of several false negatives. Our approach in reducing the number of tests was prioritizing SNPs with a heightened prior probability of association...
Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide as...
Background While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified var...
Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide as...
Multiple myeloma (MM) is a plasma cell malignancy, originating from the bone marrow. Over the past d...
Multiple myeloma (MM) is a malignancy characterised by the clonal expansion of plasma cells primaril...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Background: While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified va...
Background: While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified va...
Background: While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified va...
Background: While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified va...
BACKGROUND: Genetic background plays a role in multiple myeloma susceptibility. Several single-nucl...
BACKGROUND: Genetic background plays a role in multiple myeloma susceptibility. Several single-nucl...
BACKGROUND: Genetic background plays a role in multiple myeloma susceptibility. Several single-nucl...
Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide as...
Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide as...
Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide as...
Background While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified var...
Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide as...
Multiple myeloma (MM) is a plasma cell malignancy, originating from the bone marrow. Over the past d...
Multiple myeloma (MM) is a malignancy characterised by the clonal expansion of plasma cells primaril...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Background: While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified va...
Background: While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified va...
Background: While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified va...
Background: While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified va...
BACKGROUND: Genetic background plays a role in multiple myeloma susceptibility. Several single-nucl...
BACKGROUND: Genetic background plays a role in multiple myeloma susceptibility. Several single-nucl...
BACKGROUND: Genetic background plays a role in multiple myeloma susceptibility. Several single-nucl...
Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide as...
Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide as...
Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide as...
Background While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified var...
Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide as...